{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:39:44Z","timestamp":1787744384508,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PEJ-2020-AI\/BMD-19491"],"award-info":[{"award-number":["PEJ-2020-AI\/BMD-19491"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013941","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PRE2022-102804"],"award-info":[{"award-number":["PRE2022-102804"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119052","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:48:23Z","timestamp":1769168903000},"page":"119052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The inhibition of Il1\u03b2 synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-3829","authenticated-orcid":false,"given":"\u00c1ngela","family":"Berlana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fresno-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gomez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Garc\u00eda-Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-2318","authenticated-orcid":false,"given":"\u00c1gueda","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119052_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.biopha.2026.119052_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2026.119052_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.biopha.2026.119052_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.biopha.2026.119052_bib5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119052_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119052_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2026.119052_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888392","article-title":"Systematic review of safety and efficacy of IL-1-targeted biologics in treating immune-mediated disorders","volume":"13","author":"Arnold","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119052_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113620","article-title":"Discovery of novel 2,3,5-trisubstituted pyridine analogs as potent inhibitors of IL-1\u03b2 via modulation of the p38 MAPK signaling pathway","volume":"223","author":"Carrasco","year":"2021","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2026.119052_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.fct.2015.03.029","article-title":"Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection","volume":"80","author":"Pardo","year":"2015","journal-title":"Food Chem. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119052_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the l-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"6","key":"10.1016\/j.biopha.2026.119052_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2026.119052_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"BLIGH","year":"1959","journal-title":"Can. J. Biochem Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119052_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.185.9.1661","article-title":"Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn","volume":"185","author":"Meng","year":"1997","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.biopha.2026.119052_bib15","first-page":"2757","article-title":"Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene","volume":"10","author":"Isshiki","year":"1990","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119052_bib16","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1700845","article-title":"Palmitate Conditions Macrophages for Enhanced Responses toward Inflammatory Stimuli via JNK Activation","volume":"199","author":"Riera-Borrull","year":"2017","journal-title":"J. Immunol."},{"issue":"5596","key":"10.1016\/j.biopha.2026.119052_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1071914","article-title":"\u2018The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation","volume":"298","author":"Hoffmann","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2026.119052_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"issue":"5","key":"10.1016\/j.biopha.2026.119052_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2026.119052_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s10753-020-01190-4","article-title":"Mice deficient in the IL-1\u03b2 Activation Genes Prtn3, Elane, and Casp1 Are protected against the development of obesity-induced NAFLD","volume":"43","author":"Mirea","year":"2020","journal-title":"Inflammation"},{"issue":"105","key":"10.1016\/j.biopha.2026.119052_bib21","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal"},{"key":"10.1016\/j.biopha.2026.119052_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109587","article-title":"A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"115","author":"Jin","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.119052_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114570","article-title":"Compound J27 alleviates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease by targeting JNK","volume":"154","author":"Ye","year":"2025","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119052_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.06.010","article-title":"The PPAR\u03b1-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway","volume":"20","author":"Vernia","year":"2014","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.biopha.2026.119052_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107265","article-title":"IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis","volume":"9","author":"Negrin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119052_bib26","unstructured":"\u2018Kineret | European Medicines Agency (EMA)\u2019. Accessed: Dec. 18, 2025. [Online]. Available: \u3008https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kineret\u3009."},{"issue":"15","key":"10.1016\/j.biopha.2026.119052_bib27","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1\u2013receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:47:15Z","timestamp":1777574835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0753332226000843"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119052","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibition of Il1\u03b2 synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119052"}}